Stay updated with the latest fatty-liver-disease news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on fatty-liver-disease topics.
Bangalore : Emcure Pharmaceuticals Ltd., (BSE: 544210, NSE: EMCURE) has announced the price revision of its weight management drug Poviztra® (semaglutide injection) across India. The reduced price would be starting at Rs. 3,999/- per month (4 weekly doses). The innovator Semaglutide is available in a once-weekly pen device in five strengths of 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg and a maintenance dose of 2.4 mg. It comes in a state-of-the-art pen device that provides the convenience of simple admini ...Read More >
* Abdominal obesity poses greater health risks than overall obesity in the Indian context * Central obesity increases risk of diabetes, hypertension, cardiovascular diseases, and fatty liver * Indians tend to accumulate abdominal fat despite appearing lean, raising cardiometabolic risk Did our AI summary help? Let us know. Switch To Beeps Mode New Delhi: Abdominal or central obesity poses a greater health risk than overall obesity, especially in the Indian context where even lean-looking ...Read More >
India has officially approved the use of Ozempic (semaglutide), a once-a-week injection designed for adults with type 2 diabetes. Approved by the Central Drugs Standard Control Organisation (CDSCO), this drug has made headlines worldwide not just for diabetes management but also for its weight loss effects. As India faces rising rates of diabetes, Ozempic's arrival is more than just a medical update, it could influence lifestyle choices for millions.Here's all we need to know about what this new ...Read More >
New Delhi [India], September 30 (ANI): The Central Drugs Standard Control Organisation (CDSCO) has approved Danish drugmaker Novo Nordisk's once-a-week injection for patients suffering from Type 2 diabetes. Also Read | Durga Puja 2025: PM Narendra Modi Participates in Durga Puja Celebrations in Delhi's CR Park on Occasion of Maha Ashtami, Prays for Everyone's Happiness and Wellbeing (See Pics). In a statement provided to ANI, Novo Nordisk has stated that Ozempic is intended for individuals wit ...Read More >
Lucknow: Childhood obesity is emerging as a major health concern in the city, with doctors warning that it is leading to serious metabolic complications at an early age.The issue was raised by experts at a recent event held at a private hotel. They highlighted a study published in the International Journal of Research and Review (2024), which revealed that 29.7% of children aged 6-12 in Lucknow are either overweight or obese -- nearly three times the national average of 8.4%.The study, titled, " ...Read More >
Three Indian fertilizer companies -- IPL, KRIBHCO and Coromandel -- have signed agreements with Ma'aden, the Saudi Arabian major, for importing 3.1 million metric tonnes of Diammonium Phosphate (DAP) per annum for five years from 2025-26. The agreements were signed during Chemicals and Fertilizers Minister JP Nadda's visit to Dammam and Riyadh between July 11 [...] Three Indian fertilizer companies -- IPL, KRIBHCO and Coromandel -- have signed agreements with Ma'aden, the Saudi Arabian major, f ...Read More >
Chennai : In a meaningful step towards transforming liver cancer care in India, Apollo Proton Cancer Centre (APCC), Chennai, announced the launch of the Apollo's Advanced Liver Cancers Clinic the first-ever all-under-one-roof integrated clinic dedicated to primary liver cancers and liver metastases. The clinic was inaugurated by Mr. Radhakrishnan Thiagarajan, IPS (ADGP - Retd.) in the presence of Mr. Karan Puri, Chief Executive Officer, ACC & APCC and Dr. Sujith Kumar Mullapally, Consultant - Me ...Read More >
BHUBANESWAR: Not expensive medications, just a brisk 5-km daily walk and half-plate meal at lunch-dinner can significantly reverse nonalcoholic fatty liver disease (NAFLD) within a short period, a landmark study from Odisha has established. While NAFLD, a major precursor of serious diseases like liver cancer and cirrhosis, has emerged a leading public health problem in the country over the recent years, the study has challenged the growing dependence on medications for its treatment. Led by em ...Read More >
Lucknow: Liver fibrosis can increase the risk of cancers like colorectal, breast, and prostate by 3 to 4 times, warned Prof Gaurav Pandey from the department of gastroenterology, SGPGIMS. He spoke at a health talk titled "Fatty Liver - the Silent Epidemic" organised by the Club of Lucknow on Sunday. The event began with an address by chief secretary Manoj Kumar Singh.Prof Pandey said fatty liver disease, now called MASLD (metabolic dysfunction-associated steatotic liver disease), is often silent ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.